bian zhe tui jian

..............page:2326

juan shou yu
wang jun zhi ; shen xin liang ;

..............page:2329

zhi zhuo yao wu chuang xin , cheng jiu jian kang meng xiang zhong guo xin yao za zhi zhuan fang hai zheng yao ye gao ji fu zong cai wang hai bin jiao shou

..............page:2331-2333

WINDOW OF NEW DRUGS

..............page:2335-2336

International Pharmacovigilance Flash
ben kan ;

..............page:2337-2338

Pharmacology and clinical evaluation of the anti-angiogenesis agent ramucirumab
MA Ying;WANG Ting;MA Yi-ming;LIN Bi-rong;Shanghai CP Guojian Pharmaceutical Co.;Ltd.;

..............page:2339-2343

R&D status analysis of thymosin immunomodulators
WANG Meng-jun;Jiangsu Pacific-Meinuoke Bio-pharmaceutical Co.;Ltd.;

..............page:2344-2348

Application of data comparison analysis in lot release
MA Xiao;ZHANG Hua-jie;HOU Wen-ting;PAN Hai-long;TAN Ya-jun;National Institute for Food and Drug Control;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products;China National Pharmaceutical Group;Chengdu Institute of Biological Products Co.;Ltd.;

..............page:2349-2350+2365

Advances in approval and supervision of the similar biotherapeutic product
GUO Wei;WANG Lan;GAO Kai;National Institutes for Food and Drug Control;

..............page:2351-2355

Current approach in scientific and regulatory requirements of generic low-molecular-weight heparin
HUA Wei-li;WANG Tao;Center for Drug Evaluation;China Food and Drug Administration;

..............page:2356-2359

Development of standardized methods for quality control of humanized monoclonal antibody HcHAb18 and structure confirmation of its reference substance for physicochemical analysis
FAN Wen-hong;TAO Lei;LI Xiang;DING You-xue;HAN Chun-mei;PEI De-ning;GUO Ying;YANG Jing-qing;BI Hua;RAO Chun-ming;WANG Jun-zhi;Division of Recombinant Biological Products;Institute for Biological Product Control;NIFDC;

..............page:2360-2365

Establishment and validation of nimotuzumab identification method with capillary zone electrophoresis
GUO Wei;WANG Lan;WANG Wen-bo;ZHANG Feng;YU Chuan-fei;LI Meng;LIU Chun-yu;GAO Kai;National Institutes for Food and Drug Control;

..............page:2366-2369+2381

Development and application of capillary zone electrophoresis for purity analysis of enterovirus type 71 inactivated vaccine
WU Yun-yi;GUO Hui-jie;MA Shu-hua;CHEN Lei;WEN Zhi-heng;LU Wei-wei;LI Xiu-ling;National Vaccine & Serum Institute;

..............page:2370-2376+2405

Validation and its application of an ELISA method for the detection of anti-drug antibody against recombinant potent anti-tumor and anti-virus protein in patient sera
JIA Min;WANG Li-qing;DUAN Jin;SHENG Ai-juan;DING Shu-qin;CHEN Xi;ZHENG Feng-min;WANG Mei-xia;L Qiu-jun;National Drug Clinical Trial Institution;Beijing You’an Hospital;Capital Medical University;Beijing Genova Biotech Company;Ltd.;

..............page:2377-2381

Effect of PEG-rhGH injection on adult growth hormone deficiency in hypophysectomized rats
LI Zhan-jun;LIU Qian;LI Gang;LI Xin-xin;ZHANG Yuan;DU Ying;WU Yan-lin;HE Qing;ZHANG Heng;LIANG Cheng-gang;Gao Hua;Feng Xiao-hua;National Institutes for Food and Drug Control;Gene Science Pharmaceuticals Co.;Ltd.;

..............page:2382-2387+2393

Research progress of long-acting protein therapeutics
LIANG Cheng-gang;WANG Jun-zhi;National Institutes for Food and Drug Control;

..............page:2388-2393

Discussion on the naming of biological products
GUO Zhong-ping;Chinese Pharmacopoeia Commission;

..............page:2394-2398

zhong guo xian dai ying yong yao xue za zhi 2015 nian zheng ding qi shi

..............page:2398

Research advances in HIV vaccine: challenges and dawns
GU Jue-fen;Institute of Life Science and Technology;China Pharmaceutical University;

..............page:2399-2405

Progress in the development of innovative biologics in China
WANG Chun-ming;XIA Zhi-xing;GUO Yin-yin;ZHOU Feng;YI Bo;LI Jia;YU De-chao;Innovent Biologics;Inc;

..............page:2406-2410

Analysis of quality control of vaccine clinical trials
WANG Wen-juan;MENG Fan-yue;GAN Zheng-kai;ZHU Feng-cai;Jiangsu Provincial Centre for Disease Prevention and Control;

..............page:2411-2413+2417

Advances in research of antibody drugs
GAO Yun-hua;XU Shou-jun;DIAO Tian-xi;Institute of Health Service and Medical Information;Academy of Military Medical Sciences;Division of Project of Department of Science;Academy of Military Medical Sciences;

..............page:2414-2417

Research advances of long-acting follicle stimulating hormones
GAO Li-ting;ZHOU Li-ting;WANG Jun-ling;GAO Xiang-dong;WU Yan-zhuo;XU Ming-bo;College of Life Science and Technology;China Pharmaceutical University;Beijing SL Pharmaceutical Co.;Ltd.;

..............page:2418-2423

Present situation and deliberation of the dose-effect relationship of prescriptions and herb medicines
CHEN Hong-dong;ZHAO Lin-hua;SHEN Jian-gang;WANG Yue-sheng;XU Guo-liang;TONG Xiao-lin;Guanganmen Hospital;China Academy of Traditional Chinese Medical;School of Chinese Medicine;HKU;Jiangxi University of Traditional Chinese Medical;Institute of Chinese Materia Medica;China Academy of Chinese Medical Sciences;

..............page:2424-2429

Structure design of bispecific antibodies and progress in the assembly process
LI Xiao-wei;LIU Hui-fang;WANG Hai-bin;LI Feng;Mabworks Biotech Co. Ltd.;Zhejiang Hisun Pharmaceutical Co.;Ltd.;

..............page:2430-2436

2’,5’-Oligoadenylate synthetase as a molecular index of pharmacodynamics of anti-virus protein in phase I clinical trial
JIA Min;WANG Li-qing;CHEN Xi;DUAN Jin;SHENG Ai-juan;ZHENG Feng-min;WANG Mei-xia;L Qiu-jun;Beijing You’an Hospital;Capital Medical University;Beijing Genova Biotech Company;Ltd.;

..............page:2437-2441

Identification of cleavage site in hinge region of monoclonal antibody A in liquid formulation
DING Ding;MIAO Zhen-hua;WANG Zhao;FANG Wei-jie;WANG Hai-bin;HisunPharma Co.;Ltd.;Zhejiang Hisun Pharmaceutical Co.;Ltd.;

..............page:2442-2445+2449

Application of ACFM in varicella vaccine production
MA Xiang-hu;SHEN Yi-qing;YANG Yue-lian;ZHOU Feng;XIE Lei;SHU Zhi-long;ZHOU Ling-qiao;WANG Liang;Shanghai Institute of Biological Products Co.;Ltd.;

..............page:2446-2449

Preparation and calibration of the national reference for titration of live attenuated mumps vaccine virus
LI Hong;LI Juan;YUAN Li-yong;YI Min;QUAN Ya-ru;LI Chang-gui;National Institutes for Food and Drug Control;

..............page:2450-2452

In vitro stability and proteolysis mechanism of several novel synthesized peptides
YAO Jin-feng;ZHANG Rui-feng;SU Chun-mei;SONG Ya-fang;Yanjing Medical College;Capital Medical University;

..............page:2453-2458+2423

di san jie chuang xin zhong yao ji zhi wu yao guo ji gao feng lun tan ji shi yu bao dao

..............page:2459-2460